479 related articles for article (PubMed ID: 27473117)
1. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells.
Wang J; Li L; Wu K; Ge W; Zhang Z; Gong L; Yuan D
Pharmazie; 2016 Oct; 71(10):598-602. PubMed ID: 29441929
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein promotes tongue squamous cell carcinoma chemoresistance by inhibiting the activation of caspase-3/9 via the CD64/AKT/mTOR pathway.
Yan X; Cao M; Wang Z; Wang S; Chen Q
Hum Cell; 2021 Sep; 34(5):1424-1433. PubMed ID: 34019244
[TBL] [Abstract][Full Text] [Related]
5. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
6. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo.
Chen S; Hu H; Miao S; Zheng J; Xie Z; Zhao H
Tumour Biol; 2017 May; 39(5):1010428317705330. PubMed ID: 28513299
[TBL] [Abstract][Full Text] [Related]
8. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
Zhuang XM; Zhou B
J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
[TBL] [Abstract][Full Text] [Related]
11. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N
Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659
[TBL] [Abstract][Full Text] [Related]
12. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
[TBL] [Abstract][Full Text] [Related]
13. MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4.
Ren W; Wang X; Gao L; Li S; Yan X; Zhang J; Huang C; Zhang Y; Zhi K
Mol Cell Biochem; 2014 May; 390(1-2):253-62. PubMed ID: 24609942
[TBL] [Abstract][Full Text] [Related]
14. Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.
Gu Y; Fan S; Xiong Y; Peng B; Zheng G; Yu Y; Ouyang Y; He Z
FEBS Lett; 2011 Mar; 585(6):881-7. PubMed ID: 21334329
[TBL] [Abstract][Full Text] [Related]
15. miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1.
Fan S; Chen WX; Lv XB; Tang QL; Sun LJ; Liu BD; Zhong JL; Lin ZY; Wang YY; Li QX; Yu X; Zhang HQ; Li YL; Wen B; Zhang Z; Chen WL; Li JS
Cancer Lett; 2015 Jul; 362(2):183-91. PubMed ID: 25843291
[TBL] [Abstract][Full Text] [Related]
16. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
[TBL] [Abstract][Full Text] [Related]
18. Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma.
Lv Z; Yang Y; Yang C
Int J Oncol; 2020 Jan; 56(1):69-84. PubMed ID: 31789398
[TBL] [Abstract][Full Text] [Related]
19. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
20. Survivin shRNA induces caspase-3-dependent apoptosis and enhances cisplatin sensitivity in squamous cell carcinoma of the tongue.
Xu JH; Wang AX; Huang HZ; Wang JG; Pan CB; Zhang B
Oncol Res; 2010; 18(8):377-85. PubMed ID: 20441052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]